Clearance of recalcitrant warts in a patient with idiopathic immune deficiency following administration of the quadrivalent human papillomavirus vaccine | Zendy

Smith S. P. | Zendy; Baxendale H. E. | Zendy; Sterling J. C. | Zendy

Premium

Clearance of recalcitrant warts in a patient with idiopathic immune deficiency following administration of the quadrivalent human papillomavirus vaccine

Author(s) -

Smith S. P.,

Baxendale H. E.,

Sterling J. C.

Publication year - 2017

Publication title -

clinical and experimental dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.587

H-Index - 78

eISSN - 1365-2230

pISSN - 0307-6938

DOI - 10.1111/ced.13038

Subject(s) - medicine , human papillomavirus , immune system , dermatology , immunology , human papillomavirus vaccine , genital warts , human immunodeficiency virus (hiv) , cancer , cervical cancer , gardasil , syphilis

Summary Human papillomavirus ( HPV )‐induced cutaneous warts are potentially serious and debilitating. In immunosuppressed patients, these warts may be resistant to standard therapies. We report a case of a young patient with a primary immune deficiency whose recalcitrant cutaneous warts regressed completely following administration of a quadrivalent HPV vaccine.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research